In late July 2026, an article published in the journal Science revealed, more than a year after the event took place, the death of a six-year-old girl following a gene therapy trial in China. This therapy was based on new techniques of genetic modification (so-called new genomic techniques – NGT) and used viral vectors to deliver the gene modifying material to the target cells.
